Detalles de la búsqueda
1.
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults.
J Infect Chemother
; 29(11): 1061-1067, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524201
2.
Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data.
Allergol Int
; 71(1): 47-54, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34493447
3.
Catastrophic health expenditure on acute coronary events in Asia: a prospective study.
Bull World Health Organ
; 94(3): 193-200, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26966330
4.
Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia.
Respirology
; 21(1): 119-27, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26394882
5.
Real-life effectiveness of budesonide/formoterol therapy in asthma: A subanalysis of the SMARTASIA study.
Allergy Asthma Proc
; 37(1): 27-34, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26831844
6.
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.
Vaccine
; 41(29): 4199-4205, 2023 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271703
7.
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.
Int J Infect Dis
; 114: 165-174, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688944
8.
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study).
Ther Adv Med Oncol
; 12: 1758835920904522, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32127924
9.
Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.
Am J Respir Crit Care Med
; 177(12): 1348-57, 2008 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18337594
10.
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer.
Cancer Chemother Pharmacol
; 83(5): 849-858, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30762084
11.
The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China.
Ther Adv Respir Dis
; 13: 1753466619853500, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240995
12.
The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies.
Influenza Other Respir Viruses
; 12(4): 438-445, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29573143
13.
Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer.
Breast Cancer
; 23(5): 771-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26350351
14.
Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).
Clin Cardiol
; 38(9): 511-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26206158
15.
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.
J Thorac Oncol
; 10(3): 438-45, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25376513
16.
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
J Thorac Oncol
; 9(2): 154-62, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24419411
17.
Survey of atherosclerotic disease in Asian subjects with cardiovascular disease risk factors who were not receiving lipid-lowering agents.
Int J Cardiol
; 168(3): 2761-6, 2013 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23618432
18.
Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.
J Thorac Oncol
; 7(1): 115-21, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21900837
19.
Disease control as a predictor of survival with gefitinib and docetaxel in a phase III study (V-15-32) in advanced non-small cell lung cancer patients.
J Thorac Oncol
; 5(7): 1042-7, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20453692
20.
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.
J Clin Oncol
; 26(26): 4244-52, 2008 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779611